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Abstract. The experiment was carried out in female white Wistar rats to investigate the effect of 
L-norvaline, rosuvastatin and their combination on parameters of blood supply to the bone tissue 
on models of experimental osteoporosis and osteoporotic fractures. It was found that the studied 
drugs prevent reduction of microcirculation in osteoporotic bone tissue as well as in callus tissue 
of experimental osteoporotic fractures and it positively influences the course of reparative 
regeneration of bone tissue. 
Keyword: osteoporosis, osteoporotic fracture, microcirculation, endothelial dysfunction,  
L-norvaline, rosuvastatin, Bivalos. 
 
Introduction 
The World Health Organization defines 
osteoporosis as “a systemic disease of skeleton, 
characterized by low density of bone tissue and its 
microarchitecture defects”, that leads to high bone 
fragility and high fracture risks. The modifiable 
factors of osteoporotic disorders are low level of 
calcium and vitamin D, sedentary life-style, smoking, 
alcohol abuse, long-term glucocorticoid therapy and  
rheumatoid arthritis. The non modifiable factors 
includes advanced age, genetic predisposition, rapid 
weight loss and menopause [1, 2, 3]. 
According to the National Osteoporosis 
Foundation, ten million people in the USA have 
osteoporosis and 80% of them are women. Fractures 
are considered one of the main reasons of physical 
inactivity in elderly women, this significantly reduces 
their life quality. 
Russian and foreigner orthopedic trauma 
specialists, state that fractures of neck of the femur is 
the most typical osteoporotic complication and the 
mortality rate is up to 30% during the first six months.  
The number of surgical procedures on bone 
fractures using different implants is growing every year, 
including the use of endoprosthesis for large joints. 
According to recent investigations, each fifth operation 
of primary endoprosthesis replacement includes one re-
replacement manipulation. This is generally connected 
with the development of aseptic instability due to 
osteoporotic disorders in bone tissue.  
Blood circulation plays a significant role in bone 
tissue normal functioning. An important feature of 
the bone microvasculature is that the vessel wall does 
not have muscle and connective tissue layers, it 
consists only of the endothelial layer. Consequently, 
the humoral regulation between the osteocytes and 
blood is mediated by the endothelium. According to 
many authors, the imbalance between the processes 
of bone resorption and osteogenesis is based on 
endothelial dysfunction [4, 5, 6, 7, 8, 9, 10].  
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Norvaline (α-aminovaleric acid, propyl glycine) 
is a unconventional amino acid which is part of some 
proteins, in animals it is the antagonist of valine and 
leucine. L-norvaline is an inhibitor of arginase (a 
pharmacological agent with mechanism of action 
directed in blocking the arginase activity, thus 
increasing the concentration of L-arginine and, 
consequently increasing nitric oxide in serum) an 
enzyme that catalyses the cleavage of L-arginine, a 
substrate for nitric oxide, that is a powerful vascular 
endothelial mediator functioning on ornithine and 
urea [11, 12, 13, 14, 15].  
L-norvaline is one of those substances, however 
its effect on the bone tissue microcirculation has not 
previously been investigated. This fact is the reason 
for the present research.  
It is widely known that statins have an indirect 
corrective effect on endothelial dysfunction through the 
normalization of lipid profile and by direct effect on the 
endothelium (regardless of changes in lipid profile).  
Possible mechanisms for improvement of 
endothelial functioning in the administration of 
statins is achieved through increased production of 
nitric oxide (NO), with beneficial effect on the 
expression of endothelial NO-synthase, decreased 
secretion of endothelin-1 and increased synthesis of 
prostacyclin, which positively affects the balance 
shift vasoconstrictors/vasodilators in favour of 
vasodilation, restoration of high content of plasma 
vascular endothelial growth factor (VEGF) and the 
induction of apoptosis in endothelial cells. 
Rosuvastatin is a medication from statins group. 
In the available literature there is a wide variety of 
works about the role of statins in the correction of 
endothelial dysfunction, however, data about their 
effects on the bone tissue microcirculation is not 
sufficient. 
Based on the powerful endothelial protective 
effect of arginase inhibitor, L-norvaline, and 
selective and competitive inhibitor of HMG-CoA 
reductase, rosuvastatin. A scientific interest on the 
study of their combined use has arisen, as 
implemented in this research. 
Objectives. To study the effect of L-norvaline, 
rosuvastatin and their combination in the bone tissue 
microcirculation after experimental models of 
osteoporosis and fractures of proximal femur in 
Wistar rats.  
Methods and materials. The experiment 
involved 240 female Wistar rats weighing 200-250g. 
Manipulations were performed with animals under 
general anesthesia (intraperitoneal injection of an 
aqueous solution of chloral hydrate at a dose of 
300 mg/kg).  
The animals were divided into eight groups –  
20 rats each.  
I – Intact – false bilateral oophorectomy surgery 
(performed abdominal incision without removal of 
the ovaries, followed by wound closure); 
II – Control – true bilateral oophorectomy surgery 
(performed abdominal incision with removal of the 
ovaries, followed by wound closure) [16, 17, 18]; 
III – 8 weeks after oophorectomy and development 
of osteoporosis L-norvaline was daily administrated 
intragastrically, at a dose of 10mg/kg from the ninth to 
twelfth week [19]; 
IV – 8 weeks after oophorectomy, rosuvastatin 
was daily administered intragastrically, at a dose of 
0.86mg/kg from the ninth to twelfth week; 
V – 8 weeks after oophorectomy, a combination 
of L-norvaline at a dose of 10mg/kg, and rosuvastatin 
at a dose of 0.86mg/kg, was daily administered 
intragastrically from the ninth to twelfth week; 
VI – 8 weeks after oophorectomy, a drug for 
comparison, Bivalos (strontium ranelate) was daily 
administered intragastrically at a dose of 171mg/kg 
from the ninth to twelfth week; 
VII –  8 weeks after false oophorectomy, a 
model fracture of the proximal femoral metaphysis 
was performed; 
VIII – 8 weeks after bilateral oophorectomy, a 
model fracture of the proximal femoral metaphysis 
was performed; 
IX – 8 weeks after oophorectomy, a model 
fracture of the proximal femoral metaphysis was 
performed with further daily intragastrical 
administration of L-norvaline at a dose of 10mg/kg 
from the ninth to twelfth week; 
X – 8 weeks after oophorectomy, a model 
fracture of the proximal femoral metaphysis was 
performed with further daily intragastrical 
administration of rosuvastatin at a dose of 0.86mg/kg 
from the ninth to twelfth week; 
XI – 8 weeks after oophorectomy, a model 
fracture of the proximal femoral metaphysis was 
performed with further daily intragastrical 
administration of a combination of L-norvaline at a 
dose 10mg/kg and rosuvastatin at a dose 0.86mg/kg 
from the ninth to twelfth week; 
XII – 8 weeks after oophorectomy, a model 
fracture of the proximal femoral metaphysis was 
performed with further daily intragastrical 
administration of a drug for comparison, Bivalos, at a 
dose 171mg/kg from the ninth to twelfth week. 
Fractures were induced by close method using a 
cutting blade, the cutting edges were  covered with 
rubber tubes and external force was applied 
perpendicular to the axis of the limbon the proximal 
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metaphysis of the femur, the pressure was applied 
until the characteristic signs of fracture (abnormal 
motility and crepitations on bone fragments) were 
present. After that the fractures were stabilized by K- 
wires (1 mm in diameter) inserted intramedullary 
from the distal to  the proximal part of the femur.  
For measurement of the level of 
microcirculation in the proximal femoral metaphysis, 
conducted after 12 weeks (on the eighty-fifth day), 
equipment manufactured by Biopac systems were 
used: namely the polygraph MP150 unit with laser 
Doppler flowmetry (LDF) module LDF100C and 
invasive needle probe TSD144. A hole was drilled in 
the cortical layer of bone tissue with a depth of 2-
3mm, into which the needle of sensor probe was 
placed. The data of laser Doppler flowmetry was 
processed and recorded by software AcqKnowledge 
version 4.1, the values were expressed in 
microcirculatory perfusion units (PU).  
To confirm the endothelial vessels dysfunction and 
the degree of correction of the studied medication after 
oophorectomy in the I, II, III, IV, V and VI groups, tests 
were conducted based on the endothelium dependent 
vasodilation (EDVD) and endothelium non dependent 
vasodilation (ENVD) in response to intravenous bolus 
solutions of acetylcholine at a dose of 40µg/kg and 
sodium nitroprusside at a dose of 30µg/kg, respectively. 
After that the coefficient of endothelial dysfunction 
(CED) was calculated based on the LDF on the bone. It 
is defined as the ratio of the triangular area over 
recovery curve of microcirculation in response to the 
administration of sodium nitroprusside to the triangular 
ares over the recovery curve of microcirculation in 
response to the administration of acetylcholine.  
Statistical analysis of primary data was carried 
out in the program Microsoft Excel. “Descriptive 
statistics” was used to calculate the average value 
(M) and error of the mean (m). Assessment of the 
statistical significance of differences between groups 
was based on “two-sample t-test with different 
variances”. The differences were considered 
statistically significant for values of p <0,05.  
Results. Experiment results found that the 
"intact" animals level of microcirculation in the 
proximal metaphysis of the femur, 12 weeks after the 
beginning of the experiment, was 99.91 ± 3.41 PU, 
which was significantly greater than in the control 
group of rats with osteoporosis (58.75 ± 3.76 PU). 
Based on the calculation of the coefficient of 
endothelial dysfunction, a significant increase of this 
index was found in rats with osteoporosis (CED = 
2.57 ± 0.23) compared to "intact" animals (CED = 
1.28 ± 0.18), indicating the formation of signs of 
endothelial dysfunction, including the 
microcirculation in the bone tissue (Table 1).   
 
Table 1 
Effect of L-norvaline, rosuvastatin and their 
combination on coefficient of endothelial dysfunction 
and microcirculation of proximal femoral 
metaphysis of rats in modeling of endothelial 
dysfunction and osteoporosis by bilateral 
oophorectomy (M ± m, n=20) 
Groups of animals CED 
Microcirculation, 
PU 
Intact 1.28 ± 0.18 99.91 ± 3.41 
Control 
(osteoporosis) 
2.57 ± 0.23 * 58.75 ± 3.76 * 
L-norvaline 
10mg/kg 
1.64 ± 0.21 ** 92.46 ± 2.29 ** 
Rosuvastatin 
0.86mg/kg 
1.72 ± 0.18 ** 81.88 ± 3.39 ** 
L-norvaline 
10mg/kg + 
Rosuvastatin 
0.86mg/kg 
1.68 ± 0.25 ** 88.02 ± 3.03 ** 
Bivalos 171mg/kg 2.44 ± 0.19 67.48 ± 2.98 
 
Note: CED – coefficient of endothelial dysfunction; * – 
p<0.05 as compared to intact animals; ** – p<0.05 as 
compared to control group. 
 
Thus, after 12 weeks of bilateral oophorectomy 
female rats developed dysfunction of vascular 
endothelium, including the microcirculation of bone 
tissue. The consequence of  the endothelial 
dysfunction is the decreased regional 
microcirculation, which leads to an imbalance of 
bone remodelling and consequently, the appearance 
and development of osteoporotic changes. 
The treatment of osteoporosis using recombinant 
L-norvaline, rosuvastatin and their combination  has 
shown an improvement  in microcirculation of 
proximal femoral metaphysis of laboratory animals 
(92.46 ± 2.29 PU, 81.88 ± 3.39 PU and 88.02 ± 3.03 
PU respectively), in contrast to the reference drug 
Bivalos, despite the trend towards improvement 
(67.48 ± 2.98 PU, p=0.077). Moreover L-norvaline 
10mg/kg, rosuvastatin 0.86mg/kg, and their 
combination has also endothelial protective effect, 
effectively reducing the rate to values CED 1.64 ± 
0.21 (for L-norvaline), 1.72 ± 0.18 (for rosuvastatin), 
and 1.68 ± 0.25 (for a combination) that can cause 
improvement of regional microcirculation. In 
BIVALOS endotheliotropic properties were found 
(CED = 2.44 ± 0.19) (Table 1). 
The experimental models of proximal femoral 
metaphyseal fractures showed a similar pattern. The 
reparative regeneration processes in rats with 
osteoporosis had a statistically significant decrease in 
microcirculation in callus tissue (66.59 ± 3.61 PU) 
compared with animals with hip fractures without 
osteoporosis (89.30 ± 4.75 PU). The fracture 
consolidation in animals with osteoporotic femoral 
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fractures occurred in 55% of cases, while in animals 
without osteoporosis in 75% (Table 2).  
Table 2 
Effect of L-norvaline, rosuvastatin and their 
combination on microcirculation of callus tissue and 
consolidation in proximal femoral metaphysis of rats 
in modeling of osteoporotic fractures (M ± m, n=20) 
Groups of animals 
Microcirculation, 
PU 
Consolidation, 
% 
Fracture 89.30 ± 4.75 75 
Osteoporotic 
fracture (OF) 
66.59 ± 3.61 * 55 * 
OF + L-norvaline 
10mg/kg 
107.14 ± 3.37 ** 100 ** 
OF + Rosuvastatin 
0.86mg/kg 
94.34 ± 2.54 ** 
100 ** 
OF + L-norvaline 
10mg/kg + 
Rosuvastatin 
0.86mg/kg 
104.1 ± 3.90 PU 
** 
100 ** 
OF + Bivalos 
171mg/kg 
70.39 ± 2.39 
100 ** 
 
Note: * – p<0.05 as compared to animals with fractures; 
** – p<0.05 as compared to osteoporotic fractures group. 
 
L-norvaline at a dose of 10mg/kg effectively 
increased microcirculation parameters in callus tissue 
in proximal femoral metaphysis up to 107.14 ± 3.37 
PU, that creates favorable conditions for fracture 
consolidation on the background of osteoporosis. 
Rosuvastatin at a dose of 0.86mg/kg increased 
microcirculation parameters up to 94.34 ± 2.54 PU 
and its combination with L-norvaline up to 104.1 ± 
3.90 PU (Table 2).  
In comparison the drug Bivalos tended to 
increase the microcirculation in the callus of the 
proximal femoral metaphyseal fracture in 
osteoporotic rats without passing the threshold of 
statistical significance (70.39 ± 2.39 PU, 
p = 0.386). It is worth mention that consolidation of 
experimental osteoporotic fractures under the 
influence of L-norvaline, rosuvastatin and their 
combination occurred in 100% of cases (Table 2). 
The drug used for comparison – Bivalos – had a 
tendency to increase microcirculation parameters in 
callus tissue in proximal femoral metaphysis in rats 
with osteoporosis, but it didn’t overcome the 
statistically significant numbers (70.39 ± 2.39 PU, 
p=0.386). Experimental fracture consolidation using 
Bivalos also occurred  in 100% cases (Table 2).  
 
Conclusion: 
1. Twelve weeks after bilateral oophorectomy 
in female rats, signs of endothelial dysfunction were 
present, including the microcirculation of bone 
tissue, with a consequent reduction of regional 
indicators of microcirculation, which may adversely 
affect the "quality" of bone, leading to osteoporosis. 
2. The administration of L-norvaline at a dose 
10mg/kg, rosuvastatin at a dose 0.86mg/kg, and the 
combination of L-norvaline and rosuvastatin at 12 
weeks after bilateral oophorectomy, unlike the 
reference drug Bivalos, has endothelial protective 
action, manifested in the reduction of endothelial 
dysfunction, as well as significantly increase in the 
level of microcirculation in the metaphyseal bone of 
the proximal femur, favourably influencing the 
processes of bone remodelling. 
3. Consolidation of osteoporotic fractures of the 
femur in rats at 12 weeks after oophorectomy was 
accompanied by decrease of microcirculation in 
callus tissue, consequently leading to poor 
consolidation parameters.  
4. The administration of L-norvaline 10mg/kg, 
rosuvastatin 0.86mg/kg and their combination had 
increased microcirculation parameters in callus tissue in 
rats with proximal femoral metaphysis fracture and 
provided favorable conditions for reparative 
regeneration, which led to an increase in performance 
of experimental consolidation of osteoporotic fractures. 
Bivalos also had a positive influence on the 
consolidation of femoral fractures of osteoporotic rats. 
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